Descriptor English: | Myasthenia Gravis, Autoimmune, Experimental | ||||||
Descriptor Spanish: |
Miastenia Gravis Autoinmune Experimental
| ||||||
Descriptor Portuguese: | Miastenia Gravis Autoimune Experimental | ||||||
Descriptor French: | Myasthénie auto-immune expérimentale | ||||||
Entry term(s): |
Autoimmune Experimental Myasthenia Gravis Experimental Autoimmune Myasthenia Gravis, Passive Transfer Experimental Myasthenia Experimental Myasthenia Gravis Experimental Myasthenias Myasthenia Gravis, Autoimmune Experimental Myasthenia Gravis, Experimental Myasthenia Gravis, Experimental Autoimmune Myasthenia, Experimental Myasthenias, Experimental Passive Transfer Experimental Autoimmune Myasthenia Gravis |
||||||
Tree number(s): |
C10.114.656.300 C10.114.703.350 C10.668.758.725.300 C20.111.258.500.300 C20.111.258.625.350 E05.598.500.500.750 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D020720 | ||||||
Scope note: | Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3) |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Autoimmune Diseases (1969-1999) Myasthenia Gravis (1968-1999) |
||||||
Public MeSH Note: | 2005; see MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE 2000-2004 |
||||||
History Note: | 2005 (2000) |
||||||
DeCS ID: | 34209 | ||||||
Unique ID: | D020720 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2000/01/01 | ||||||
Date of Entry: | 1999/11/05 | ||||||
Revision Date: | 2004/07/13 |
-
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Investigative Techniques [E05]Investigative Techniques
|
Myasthenia Gravis, Autoimmune, Experimental
- Preferred
Experimental Autoimmune Myasthenia Gravis, Passive Transfer
- Narrower
Concept UI |
M0328219 |
Scope note | Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor (AChR) (see RECEPTORS, CHOLINERGIC) components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (From Joynt, Clinical Neurology, 1997, Ch 54, p3) |
Preferred term | Myasthenia Gravis, Autoimmune, Experimental |
Entry term(s) |
Autoimmune Experimental Myasthenia Gravis Experimental Myasthenia Experimental Myasthenia Gravis Experimental Myasthenias Myasthenia Gravis, Autoimmune Experimental Myasthenia Gravis, Experimental Myasthenia Gravis, Experimental Autoimmune Myasthenia, Experimental Myasthenias, Experimental |
Concept UI |
M0334367 |
Preferred term | Experimental Autoimmune Myasthenia Gravis, Passive Transfer |
Entry term(s) |
Passive Transfer Experimental Autoimmune Myasthenia Gravis |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey